NCT06256432View on ClinicalTrials.gov

Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome

PHASE2RecruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

April 17, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

February 28, 2026

Conditions
Hepatorenal SyndromeLiver CirrhosisAcute Kidney InjuryAscites Hepatic
Interventions
DRUG

Ambrisentan

Endothelin receptor antagonist

DRUG

Terlipressin

Terlipressin

Trial Locations (6)

110029

RECRUITING

All India Institute of Medical Sciences, New Delhi

208002

RECRUITING

Ganesh Shankar Vidyarthi Memorial (GSVM) Medical College, Kanpur

226030

RECRUITING

Medanta Multi Super Specialty Hospital, Lucknow

400004

RECRUITING

Sir HN Reliance Hospital Foundation, Mumbai

500082

RECRUITING

Asian Institute of Gastroenterology (AIG), Hyderabad

560092

RECRUITING

Aster CMI Hospital, Bangalore

Sponsors
All Listed Sponsors
lead

Noorik Biopharmaceuticals AG

INDUSTRY